Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers-Reference-Cited by-同舟云学术

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

Published:2005-12 Issue:6 Volume:66 Page:35-63
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Lokeshwar Vinata B.,Habuchi Tomonori,Grossman H. Barton,Murphy William M.,Hautmann Stefan H.,Hemstreet George P.,Bono Aldo V.,Getzenberg Robert H.,Goebell Peter,Schmitz-Dräger Bernd J.,Schalken Jack A.,Fradet Yves,Marberger Michael,Messing Edward,Droller Michael J.

Publisher

Elsevier BV

Subject

Urology

Reference212 articles.

1. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma;Droller;J Urol,2001

2. Current bladder tumor tests does their projected utility fulfill clinical necessity?;Lokeshwar;J Urol,2001

3. Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder;Lotan;J Urol,2002

4. A user’s guide to flexible cystoscopy;Pope;Br J Urol,1991

5. Diagnostic work-up;Nijima,1986

Cited by 366 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomorphological characteristics of low‐grade papillary urothelial carcinoma in voided urine samples: Distinction from benign and high‐grade papillary urothelial carcinoma;Cytopathology;2024-07-11

2. Clinical Validation of the Proenkephalin (PENK) Methylation Urine Test for Monitoring Recurrence of Non–muscle-invasive Bladder Cancer;European Urology Open Science;2024-04

3. Multiple Fluorescences in Situ Hybridization Status in Excreted Urine Improve Diagnostic Efficacy for Upper Urinary Tract Urothelial Carcinomas;UROL J;2024

4. New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine;Cancers;2024-02-16

5. Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group;Journal of Clinical Oncology;2023-12-10